HELPING THE OTHERS REALIZE THE ADVANTAGES OF LDN-27219 AS A CANCER DRUG CANDIDATE

Consensus sequence for tTG crosslinking substrates. Alignment of all glutamine-donor crosslinking substrates described within the Transdab database demonstrates that apart from glutamine (Q at place 0), There exists minor to no favoritism for different residues at up to 5 positions right before or once the glutamine residue to generally be crosslin